This is consistent with a previous study reporting lower levels of G6PD enzymatic activity in patients with rheumatoid arthritis and Sjögren’s syndrome, which in many cases was subclinical and of acquired origin (28). This evidence concerns the gene G6PD and Sjogren syndrome.